Milo Gatti

Bologna, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 182 publications

Isavuconazole as primary antifungal prophylaxis in pediatric hematological patients: a clinical and pharmacokinetic analysis.

Isavuconazole as primary antifungal prophylaxis in pediatric hematological patients: a clinical and pharmacokinetic analysis.

Journal: Antimicrobial agents and chemotherapy

Published: June 26, 2026

Re: 'Pharmacokinetics, target attainment and outcomes of piperacillin/tazobactam in critically ill patients receiving continuous infusion with therapeutic drug monitoring: a retrospective analysis' by Chiriac et al.

Re: 'Pharmacokinetics, target attainment and outcomes of piperacillin/tazobactam in critically ill patients receiving continuous infusion with therapeutic drug monitoring: a retrospective analysis' by Chiriac et al.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: April 27, 2026

Is residual diuresis a reliable proxy of creatinine clearance for titrating the proper beta-lactam dosing regimen in septic critical OLT recipients undergoing CRRT?

Is residual diuresis a reliable proxy of creatinine clearance for titrating the proper beta-lactam dosing regimen in septic critical OLT recipients undergoing CRRT?

Journal: Journal of critical care

Published: April 10, 2026

Impact of timing of aggressive joint PK/PD target attainment of continuous infusion piperacillin-tazobactam on early clinical response of febrile neutropenia to antimicrobial treatment: insights from a prospective, monocentric, observational study in pediatric hematopoietic stem cell recipients.

Impact of timing of aggressive joint PK/PD target attainment of continuous infusion piperacillin-tazobactam on early clinical response of febrile neutropenia to antimicrobial treatment: insights from a prospective, monocentric, observational study in pediatric hematopoietic stem cell recipients.

Journal: International journal of antimicrobial agents

Published: March 31, 2026

Pharmacological approaches to overcome antimicrobial resistance in gram-negative bacterial infections: current practice and future directions.

Pharmacological approaches to overcome antimicrobial resistance in gram-negative bacterial infections: current practice and future directions.

Journal: Expert opinion on pharmacotherapy

Published: March 24, 2026

ARC in Critical Ill OLT Recipients: True Prevalence, Risk Factors, and Impact on Early Aggressive PK/PD Target Non-Attainment of CI Beta-Lactam Therapy for Posttransplant Gram-Negative Infections.

ARC in Critical Ill OLT Recipients: True Prevalence, Risk Factors, and Impact on Early Aggressive PK/PD Target Non-Attainment of CI Beta-Lactam Therapy for Posttransplant Gram-Negative Infections.

Journal: Transplant infectious disease : an official journal of the Transplantation Society

Published: March 19, 2026

Accurate and Sensitive UHPLC-Tandem Mass Spectrometry Sequential Methods for Therapeutic Drug Monitoring of Aztreonam/Avibactam in Human Plasma.

Accurate and Sensitive UHPLC-Tandem Mass Spectrometry Sequential Methods for Therapeutic Drug Monitoring of Aztreonam/Avibactam in Human Plasma.

Journal: Pharmaceutics

Published: February 21, 2026

Aggressive joint pharmacokinetic/pharmacodynamic target attainment of TDM-guided continuous infusion meropenem-vaborbactam monotherapy: A valuable strategy for maximizing the microbiological outcome of documented KPC-producing Enterobacterales infections?

Aggressive joint pharmacokinetic/pharmacodynamic target attainment of TDM-guided continuous infusion meropenem-vaborbactam monotherapy: A valuable strategy for maximizing the microbiological outcome of documented KPC-producing Enterobacterales infections?

Journal: International journal of antimicrobial agents

Published: February 06, 2026

Comparison of Ceftolozane-Tazobactam and Ceftazidime-Avibactam in the Treatment of Multidrug-Resistant/Difficult-to-Treat Resistant Pseudomonas aeruginosa Infections: A Systematic Review and Meta-analysis.

Comparison of Ceftolozane-Tazobactam and Ceftazidime-Avibactam in the Treatment of Multidrug-Resistant/Difficult-to-Treat Resistant Pseudomonas aeruginosa Infections: A Systematic Review and Meta-analysis.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: January 12, 2026

Managing Enterococcus faecium bloodstream infection: a Delphi document on clinical recommendations and research agenda.

Managing Enterococcus faecium bloodstream infection: a Delphi document on clinical recommendations and research agenda.

Journal: EClinicalMedicine

Published: January 12, 2026

Pharmacokinetics-pharmacodynamics perspective to optimizing therapy with beta-lactams in critically ill patients: an update.

Pharmacokinetics-pharmacodynamics perspective to optimizing therapy with beta-lactams in critically ill patients: an update.

Journal: Expert review of anti-infective therapy

Published: December 24, 2025

Raising the Bar of PK/PD Target Attainment of Beta-Lactams in Daily Clinical Practice: An Effective Strategy to Overcome Resistance Development to Novel Beta-Lactams?

Raising the Bar of PK/PD Target Attainment of Beta-Lactams in Daily Clinical Practice: An Effective Strategy to Overcome Resistance Development to Novel Beta-Lactams?

Journal: Infectious disease reports

Published: December 03, 2025

Showing 1-12 of 182

Last Updated: 09/26/2026